Search research articles
Contact Us
Filters
Showing results (391-400 of 602) with videos related to
Page
of 61
Sort By:
British Journal of Haematology
|
July 5, 2007
Phase II trial of the combination of denileukin diftitox and rituximab for relapsed/refractory B-cell non-Hodgkin lymphoma
Nam H Dang, Luis Fayad, Peter McLaughlin, et al.
Acta Haematologica
|
April 29, 2021
Improvements in Communication and Coordination of Care in a Hemophilia Treatment Center
Christopher J Ng, Nancy Spomer, Rick Shearer, et al.
Radiology
|
September 13, 2022
Pulse-Echo Quantitative US Biomarkers for Liver Steatosis: Toward Technical Standardization
David T Fetzer, Ivan M Rosado-Mendez, Michael Wang, et al.
Pediatric Blood & Cancer
|
September 13, 2016
Risk factors for bacteremia and central line-associated blood stream infections in children with acute myelogenous leukemia: A single-institution report
Ashley E J Rogers, Kristen M Eisenman, Susan A Dolan, et al.
Cancers
|
September 27, 2025
Application of the STRATCANS Criteria to the MUSIC Prostate Cancer Active Surveillance Cohort: A Step Towards Risk-Stratified Active Surveillance
Ana M Moser, Michael Wang, Ava Zamani, et al.
Leukemia & Lymphoma
|
March 1, 2022
Characterization of low-grade arthralgia, myalgia, and musculoskeletal pain with ibrutinib therapy: pooled analysis of clinical trials in patients with chronic lymphocytic leukemia and mantle cell lymphoma
Tanya Siddiqi, Steven Coutre, Matthew McKinney, et al.
Blood Advances
|
June 21, 2021
Zanubrutinib for the treatment of relapsed or refractory mantle cell lymphoma
Constantine S Tam, Stephen Opat, David Simpson, et al.
British Journal of Haematology
|
August 23, 2022
A phase 1b/2 clinical study of marstacimab, targeting human tissue factor pathway inhibitor, in haemophilia
Johnny N Mahlangu, Jose Luis Lamas, Juan Cristobal Morales, et al.
Urologic Oncology
|
November 16, 2024
The use of nephron-sparing intervention does not appear to be compromised after a period of active surveillance for patients with cT1 renal masses
Michael Wang, Aaron Wilke, Samuel Goorman, et al.
Pediatric Blood & Cancer
|
November 4, 2016
Measuring pediatric hematology-oncology fellows' skills in humanism and professionalism: A novel assessment instrument
Jennifer C Kesselheim, Anurag K Agrawal, Nita Bhatia, et al.
Page
of 61
Search research articles
Search
Showing results (391-400 of 602) with videos related to
Sort By:
Page
of 61
British Journal of Haematology
|
July 5, 2007
Phase II trial of the combination of denileukin diftitox and rituximab for relapsed/refractory B-cell non-Hodgkin lymphoma
Nam H Dang, Luis Fayad, Peter McLaughlin, et al.
Acta Haematologica
|
April 29, 2021
Improvements in Communication and Coordination of Care in a Hemophilia Treatment Center
Christopher J Ng, Nancy Spomer, Rick Shearer, et al.
Radiology
|
September 13, 2022
Pulse-Echo Quantitative US Biomarkers for Liver Steatosis: Toward Technical Standardization
David T Fetzer, Ivan M Rosado-Mendez, Michael Wang, et al.
Pediatric Blood & Cancer
|
September 13, 2016
Risk factors for bacteremia and central line-associated blood stream infections in children with acute myelogenous leukemia: A single-institution report
Ashley E J Rogers, Kristen M Eisenman, Susan A Dolan, et al.
Cancers
|
September 27, 2025
Application of the STRATCANS Criteria to the MUSIC Prostate Cancer Active Surveillance Cohort: A Step Towards Risk-Stratified Active Surveillance
Ana M Moser, Michael Wang, Ava Zamani, et al.
Leukemia & Lymphoma
|
March 1, 2022
Characterization of low-grade arthralgia, myalgia, and musculoskeletal pain with ibrutinib therapy: pooled analysis of clinical trials in patients with chronic lymphocytic leukemia and mantle cell lymphoma
Tanya Siddiqi, Steven Coutre, Matthew McKinney, et al.
Blood Advances
|
June 21, 2021
Zanubrutinib for the treatment of relapsed or refractory mantle cell lymphoma
Constantine S Tam, Stephen Opat, David Simpson, et al.
British Journal of Haematology
|
August 23, 2022
A phase 1b/2 clinical study of marstacimab, targeting human tissue factor pathway inhibitor, in haemophilia
Johnny N Mahlangu, Jose Luis Lamas, Juan Cristobal Morales, et al.
Urologic Oncology
|
November 16, 2024
The use of nephron-sparing intervention does not appear to be compromised after a period of active surveillance for patients with cT1 renal masses
Michael Wang, Aaron Wilke, Samuel Goorman, et al.
Pediatric Blood & Cancer
|
November 4, 2016
Measuring pediatric hematology-oncology fellows' skills in humanism and professionalism: A novel assessment instrument
Jennifer C Kesselheim, Anurag K Agrawal, Nita Bhatia, et al.
Page
of 61